Hi Fred!
As Marvin Loeb said, Vaso is playing catchup. I imagine that they have taken the comparison to heart and are working to catch up. Fred, the thing that puzzles me is that no one seems interested in investigating Cardiomedics. Information is available. I would be interested in knowing whether Cardio is also available in the 34 sites mentioned by Vaso, and if not, why not. Cardiomedical is financially very strong, like a lot of companies that have chosen not to go pubic but are doing a great job. I honestly believe their sales exceed those of vaso, perhaps because their treatment can be done in a home or in a doctor's office, and is not limited to a hospital. Since they have not gone public any information would have to come from them. But no one seems interested in investigating. This amazes me. It was when I shopped the competition, Cardiovascular, that I unloaded my 40,000 shares at 2. Have you really been impressed with their management. This is their current financial condition as of January 30.
Statistics at a Glance -- VASO
Last Updated: Jan 30, 1998
Price and Volume
(updated Jan 30, 1998)
52-Week Low
$1.531
Recent Price
$1.75
52-Week High
$3.563
Beta
1.56
Daily Volume
(3-month avg)
303.8K
Share-Related Items
Market Capitalization
$84.5M
Shares Outstanding
48.3M
Float
44.0M
Dividend Information
Annual Dividend
none
Per-Share Data
Book Value (mrq)
$0.09
Earnings (ttm)
-$0.12
Sales (ttm)
$0.06
Cash (mrq)
$0.07
Valuation Ratios
Price/Book (mrq)
20.02
Price/Earnings
N/A
Price/Sales (ttm)
27.34
Income Statements
Net Income (ttm)
-$4.70M
Sales (ttm)
$3.00M
Profitability
Profit Margin (ttm)
-188%
Management Effectiveness
Return on Assets (ttm)
-81.92%
Return on Equity (ttm)
-126.15%
Financial Strength
Current Ratio (mrq)
3.67
Total Debt/Equity (mrq)
0
Are you impressed with a book value of .09, earnings of -$0.12, net income of -$4.70, a return on assets of -81.92% and a return on equity of-126.15%? Frankly, regardless of the propaganda, I'd be scared.
Fred, why doesn't someone check out the comparative financial strength and sales volume of Cardiovascular. With money on the line, it seems to me as though that would be time well spent. They will tell you if you take the trouble to ask. I am not touting Cardio, I hope they both do well. I just can't understand why all I hear is cheerleading for Vaso with no effort to investigate Cardio. Anyway, we are back down to 1 3/4. It gets up 1/32 and then falls right back down to
1 3/4. OH, oh, it just slipped to 1 23/32. Maybe the cheerleaders ought to get some help from Leon or at least thoroughly investigate the competition.
It's always good to hear your unbiased comments. I will be interested in seeing Mr. Peacock's item by item comments on the comarison presented by Cardiovascular. They put it on the line. Based on his past evasiveness, I predict he will not accept the challenge.
Kindest regards,
Don |
